To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Gastric Cancer

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Stomach Neoplasms · Solid Tumor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
Contact: Study coordinator (yanqiao Zhang, Dr.) · yanqiaozhang@126.com · 13845120210
The First Hospital of China Medical University, Shenyang, Liaoning, China
Contact: Study coordinator (Qu Xiujuan Dr.QU) · qu_xiujuan@hotmail.com · 024-83282256
Contact: Principal Investigator (Qu Xiujuan Dr.QU, PhD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Advanced/Metastatic Solid Tumors · Colorectal Cancer · Gastric Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

La Jolla, United States · Los Angeles, United States

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

Advanced or Metastatic Solid Tumors · Triple Negative Breast Cancer (TNBC) · HR+ Breast Cancer

Abroad (travel likely)RecruitingPHASE1

Denver, United States · Houston, United States

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

Solid Tumor · Advanced Cancer · Metastatic Cancer

Abroad (travel likely)RecruitingPHASE1

Orange, United States · Aurora, United States

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

Solid Tumor, Adult · Triple Negative Breast Cancer · Colorectal Cancer

Abroad (travel likely)RecruitingPHASE1

Scottsdale, United States · La Jolla, United States